Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Inventory (2018 - 2025)

Abvc Biopharma (ABVC) has disclosed Inventory for 6 consecutive years, with $11460.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory changed N/A year-over-year to $11460.0, compared with a TTM value of $11460.0 through Sep 2025, changed N/A, and an annual FY2021 reading of $25975.0, changed N/A over the prior year.
  • Inventory was $11460.0 for Q3 2025 at Abvc Biopharma, roughly flat from $11460.0 in the prior quarter.
  • Across five years, Inventory topped out at $60007.0 in Q3 2021 and bottomed at $11460.0 in Q1 2025.
  • Average Inventory over 3 years is $23175.8, with a median of $21172.0 recorded in 2022.
  • Peak annual rise in Inventory hit 65.86% in 2022, while the deepest fall reached 65.86% in 2022.
  • Year by year, Inventory stood at $25975.0 in 2021, then dropped by 21.12% to $20489.0 in 2022, then crashed by 44.07% to $11460.0 in 2025.
  • Business Quant data shows Inventory for ABVC at $11460.0 in Q3 2025, $11460.0 in Q2 2025, and $11460.0 in Q1 2025.